Abiopharma

New Form 8-K - BioSig Technologies, Inc. Filed: 2025-08-15 AccNo: 0001641172-25-024484 Size: 747 KB Item 1.01: Entry into a Material Definitive Agreement Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits